Ajuste direto para aquisição de A53311- Acalabrutinib [100 mg; cáp/comp] e T1820- Ticagrelor [60 mg; comp]

ID 11301580 · QuemFatura.pt
Price
Base Price
€16,971 .56
Effective Price
€16,971 .00 -0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Porto, Porto
Bidder Count
1
Winner
ASTRAZENECA - PRODUTOS FARMACÊUTICOS LDA
NIF 502942240
Company
Competition
1 bidder recorded
ASTRAZENECA - PRODUTOS FARMACÊUTICOS LDA
NIF 502942240
Dates
Publication
24 Mar 2025
Celebration
26 Nov 2024
Contracting Entity
Unidade Local de Saúde de Santo António, EPE
NIF 517392259
Public body
Data Source
QuemFatura.pt
Api · synced 2026-02-27
Risk Flags
Score 90 · HIGH RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
HIGH
Authority
745
Supplier
45
Number of Awards
14
Rule
A1 repeat direct award: 14 awards within 36 months
Detected 2026-03-06
C3 · Missing Mandatory Fields
C3_MISSING_MANDATORY_FIELDS
LOW
Missing fields
["cpv_code"]
Rule
C3 missing mandatory fields: cpv_code
Detected 2026-03-06
A6 · Low Competition
A6_LOW_COMPETITION
MEDIUM
Rule
a6_single_bidder
Bidder count
1
Detected 2026-04-17